Amalgam RX
Latest round
- Series B
Last raised
- Oct 2023
Total raised
- Undisclosed
Investors
- 1
About Amalgam RX
, based in the US, specializes in integrated point-of-care solutions that optimize clinical workflows within Electronic Health Records (EHR) systems, enhancing patient outcomes and engagement through its innovative technology. Founded in 2016, Amalgam RX, Inc. operates from Wilmington, US, providing digital health solutions to healthcare providers, life sciences companies, and health plans. In August 2025, Amalgam RX, Inc.417 mn. The CEO of Amalgam RX is Ryan Sysko, who has a background in healthcare technology and entrepreneurship. Amalgam RX specializes in integrated point-of-care solutions designed to enhance clinical workflows within Electronic Health Records (EHR) systems. Their offerings include patient identification tools, clinical trial recruitment applications, care guidelines, and financial assistance mechanisms, all aimed at improving patient outcomes and engagement. Built on a configurable, AI-powered platform, these digital health solutions support medication adherence, patient education, and device integration, ultimately striving to optimize treatment regimens and improve quality of life.Amalgam RX generates revenue primarily through partnerships with life sciences companies, health plans, and providers, focusing on the commercialization of digital therapeutic interventions and regulated Software as a Medical Device (SaMD). Their transactions involve B2B collaborations, integrating Amalgam's solutions into existing clinical workflows, benefiting from advanced AI capabilities and clinical validation. The company's approach emphasizes the development of customized applications based on validated modules, aligning closely with the stringent demands of the healthcare sector.
Who invested in Amalgam RX
1 investor across 1 round
See all investors in Amalgam RX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 5, 2023
Amount
Undisclosed
Investors
Questions about Amalgam RX
Who invested in Amalgam RX?
Amalgam RX has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amalgam RX raised?
Amalgam RX has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amalgam RX last raise money?
Amalgam RX's most recent round on record is a Series B, in Oct 2023.
What does Amalgam RX do?
, based in the US, specializes in integrated point-of-care solutions that optimize clinical workflows within Electronic Health Records (EHR) systems, enhancing patient outcomes and engagement through its innovative technology.
Where is Amalgam RX headquartered?
Amalgam RX is headquartered in Wilmington, US.
Which VCs invest in companies like Amalgam RX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Amalgam RX's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Amalgam RX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.